AI-Powered Behavioral Quantification for Precision Neurology
Providing Clinicians and Drug Developers a Digital Phenotyping Platform to Characterize Treatment Response and to Optimize Neurological Care
Trusted by industry leaders and world-renowned institutions.
Accelerating Neurological Drug Development and Enhancing Patient Care
With dannce.ai, you can objectively measure neurological conditions using advanced AI-driven motion analysis. Our platform transforms drug trials and clinical decision-making, helping you achieve better results faster.
Clinicians
- Improve clinical decision-making with objective behavioral insights.
- Scale patient assessments with automated, AI-powered tools.
Pharma & Biotech
- Detects subtle drug effects that traditional methods miss.
- More sensitive and objective measure of neurological state
- Leaner trials (increased sensitivity).
- Increased probability of detecting efficacy signals, leading to portfolio prioritization.
News
Latest Updates from dannce.ai
Stay informed about our latest partnerships and innovations at the intersection of AI and neurology.
Explore How AI Can Transform Neurological Care
Learn how dannce.ai can accelerate your clinical trials or improve patient outcomes with cutting-edge AI technology.
